Impact of probiotics and prebiotics targeting metabolic syndrome

被引:65
作者
Xavier-Santos, Douglas [1 ,2 ,3 ]
Bedani, Raquel [1 ,2 ]
Lima, Egidio Dorea [4 ]
Isay Saad, Susana Marta [1 ,2 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Av Prof Lineu Prestes 580,B16, BR-05508000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Food Res Ctr, Sao Paulo, Brazil
[3] Univ Genoa, Pole Chem Engn, Dept Civil Chem & Environm Engn, Via Opera Pia 15, I-16145 Genoa, Italy
[4] Univ Sao Paulo, Univ Hosp, Av Prof Lineu Prestes 2565, BR-05508000 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Probiotics; Functional foods; Intestinal microbiota; Dysbiosis; Metabolic disorders; TYPE-2; DIABETES-MELLITUS; INTERNATIONAL SCIENTIFIC ASSOCIATION; GLUCAGON-LIKE PEPTIDE-1; SERUM-LIPID PROFILE; C-REACTIVE PROTEIN; GUT MICROBIOTA; LACTOBACILLUS-PLANTARUM; DOUBLE-BLIND; AKKERMANSIA-MUCINIPHILA; INSULIN-RESISTANCE;
D O I
10.1016/j.jff.2019.103666
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Several studies are contributing to the better understanding of the impact of probiotics and prebiotics on the modulation of the intestinal microbiota and subsequent effects on the host's health. This review aimed to discuss the results of studies using different experimental models to evaluate the impact of the supplementation with probiotics and/or prebiotics on the different risk factors related to metabolic syndrome (MetS). A better understanding of the daily supplementation of probiotics and prebiotics regarding the mechanisms involved in the modulation of the intestinal microbiota and the immune system of patients suffering from this metabolic disorder is necessary to establish the efficiency of possible biomarkers that could contribute towards a health claim. Although the results might be promising, the functionality of probiotics and prebiotics on the intestinal microbiota and its relationship with MetS are still poorly understood to indicate their consumption for prevention and management of MetS in clinical practice.
引用
收藏
页数:17
相关论文
共 230 条
[21]   Assessment of insulin resistance using surrogate markers in patients of metabolic syndrome [J].
Bhatnagar, Mani K. ;
Arora, Sarika ;
Singh, Vinyas ;
Bhattacharjee, Jayashree .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2011, 5 (01) :29-32
[22]   Metabolic syndrome, obesity, and the risk of cancer development [J].
Bitzur, Rafael ;
Brenner, Ronen ;
Maor, Elad ;
Antebi, Maayan ;
Ziv-Baran, Tomer ;
Segev, Shlomo ;
Sidi, Yechezkel ;
Kivity, Shaye .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 34 :89-93
[23]   Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study [J].
Borges, Natalia A. ;
Stenvinkel, P. ;
Bergman, P. ;
Qureshi, A. R. ;
Lindholm, B. ;
Moraes, C. ;
Stockler-Pinto, M. B. ;
Mafra, D. .
PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2019, 11 (02) :648-654
[24]   Metabolic endotoxemia with obesity: Is it real and is it relevant? [J].
Boutagy, Nabil E. ;
McMillan, Ryan P. ;
Frisard, Madlyn I. ;
Hulver, Matthew W. .
BIOCHIMIE, 2016, 124 :11-20
[25]   Probiotic Supplementation and Trimethylamine-N-Oxide Production Following a High-Fat Diet [J].
Boutagy, Nabil E. ;
Neilson, Andrew P. ;
Osterberg, Kristin L. ;
Smithson, Andrew T. ;
Englund, Tessa R. ;
Davy, Brenda M. ;
Hulver, Matthew W. ;
Davy, Kevin P. .
OBESITY, 2015, 23 (12) :2357-2363
[26]   Latent class analysis of the metabolic syndrome [J].
Boyko, Edward J. ;
Doheny, Rebecca A. ;
McNeely, Marguerite J. ;
Kahn, Steven E. ;
Leonetti, Donna L. ;
Fujimoto, Wilfred Y. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (01) :88-93
[27]   Gut microbiota and inflammatory joint diseases [J].
Breban, Maxime .
JOINT BONE SPINE, 2016, 83 (06) :645-649
[28]   Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD [J].
Briskey, David ;
Tucker, Patrick S. ;
Johnson, David W. ;
Coombes, Jeff S. .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2016, 57 :64-70
[29]   Microbial modulation of cardiovascular disease [J].
Brown, J. Mark ;
Hazen, Stanley L. .
NATURE REVIEWS MICROBIOLOGY, 2018, 16 (03) :171-181
[30]   Immuno-microbiota cross and talk: The new paradigm of metabolic diseases [J].
Burcelin, Remy ;
Garidou, Lucile ;
Pomie, Celine .
SEMINARS IN IMMUNOLOGY, 2012, 24 (01) :67-74